BioCubaFarma, Productos, 2023, available at <biocubafarma.cu/productos/productos.php>..>Google Scholar

Lage, A., “Science and Challenges for Cuban Public Health in the 21st Century,” MEDICC Review 21 (2019): 7–14.Google Scholar

Lage, A., “Connecting Science to Population Health: The ‘Closed Loop’ Approach,” MEDICC Review 9 (2007): 48.Google ScholarPubMed

BioCubaFarma, supra note 1; Sierra-González, V.G., “Cuban Meningococcal Vaccine VA-MENGOC-BC: 30 Years of Use and Future Potential,” MEDICC Review 21 (2019): 19–27.Google ScholarPubMed

Zhou, Q., et al., “Interferon-α2b Treatment for COVID-19,” Frontiers in Immunology 11 (2020): 1061.CrossRefGoogle ScholarPubMed

López-Saura, P.A., et al., “Medical Practice Confirms Clinical Trial Results of the Use of Intralesional Human Recombinant Epidermal Growth Factor in Advanced Diabetic Foot Ulcers,” Advancements in Pharmacoepidemiology Drug Safety 2 (2013): 128.Google Scholar

O. Pérez Villanueva, “Biotechnology Development in Cuba: Challenges in the Economic Strategy Beyond 2021 | Cuba Capacity Building Project,” available at <https://horizontecubano.law.columbia.edu/news/biotechnology-development-cuba-challenges-economic-strategy-beyond-2021> (last visited September 13, 2023).+(last+visited+September+13,+2023).>Google Scholar

Machado, C. Castellanos and Bendoyro, J., El capital relacional en el sector biotecnológico cubano (Marta Abreu de las Villas, 2008).Google Scholar

Delgado, B. García, Di Fabio, J.L., Casanovas, J. Vidal, Fitzgerald, J., Silva, A.P., “Salud pública y propiedad intelectual en Cuba: mapa conceptual,” Revista Panamericana de Salud Pública 38 (2015): 355–361.Google Scholar

Delgado, B. García, Di Fabio, J.L., and Casanovas, J. Vidal, “Mapa conceptual sobre salud pública y propiedad intelectual en Cuba: actualización 2020,” Revista Panamericana de Salud Pública 44 (2020); B. García, E. Díaz, and E.M. Fajardo, Experiencia local en la producción local de medicamentos, transferencia de tecnología y mejoramiento en el acceso a la salud, Segunda Edición (2020).Google Scholar

WIPO, WIPO IP Statistics Data Center, 2023.Google Scholar

J. Aboites, T. Beltrán, and A. Guzmán, “Quién apropia el conocimiento producido por los inventores?” Habana IV Seminario Internacion sobre Estududios Cuantitativos y Cualitivos Inf. INFO (2008); Pérez, M. Díaz, Reyes, R. Giráldez, and Carrillo-Calvet, H.A., “Metric Behavior of Patents Granted in Cuba: Its Contribution to the National Technological Innovation,” Investig. Bibl. 31 (2017): 271–289; Ministry of Sciences & Technology, Cuba Statistics Yearbook (2023).Google Scholar

See García Delgado, et al., supra notes 9 and 10.Google Scholar

C. Martinez Diaz, Régimen jurídico de las creaciones intelectuales surgidas en el marco de relaciones laborales y de colaboración (2023).Google Scholar

See Díaz Pérez and Ministry of Sciences & Technology, supra note 12.Google Scholar

See García, et al., supra note 10.Google Scholar

See García Delgado, et al., supra notes 9 and 10.Google Scholar

Valerino, D.R.P., “Ciencia, salud y diplomacia: simbiosis necesaria en el escenario actual de las Relaciones Internacionales,” Revista Política Internacional (2020): 111–121.Google Scholar

See Zhou, supra note 5.Google Scholar

Díaz, E.M., Rodríguez, R.P., Martínez, L.H., Dávila, A.L., and Serra, L.C., “La industria biofarmacéutica cubana en el combate contra la pandemia de COVID-19,” Anales de la Academia de Ciencias de Cuba 10 (2020): 906.Google Scholar

Toledo-Romaní, M.E., et al., “Safety and Efficacy of the Two Doses Conjugated Protein-Based SOBERANA-02 COVID-19 Vaccine and of a Heterologous Three-Dose Combination with SOBERANA-Plus: A Double-Blind, Randomised, Placebo-Controlled Phase 3 Clinical Trial,” The Lancet Regional Health 18 (2023).Google ScholarPubMed

Más-Bermejo, P.I., et al., “Cuban Abdala Vaccine: Effectiveness in Preventing Severe Disease and Death from COVID-19 in Havana, Cuba; A Cohort Study,” The Lancet Regional Health - Americas 16 (2022): 100366; F. Hernández-Bernal, et al., “A Phase 3, Randomised, Double-Blind, Placebo-Controlled Clinical Trial Evaluation of the Efficacy and Safety of a SARS-CoV-2 Recombinant Spike RBD Protein Vaccine in Adults (ABDALA-3 Study),” The Lancet Regional Health 21 (2023).CrossRefGoogle ScholarPubMed

Reardon, S., “Cuba’s Bet on Home-Grown COVID Vaccines Is Paying Off,” Nature 15–16 (2021): 15–16.CrossRefGoogle Scholar

ONEI, Anuario estadístico de Cuba: Sección sector externo (2022).Google Scholar

B. Fernandez Perez, “Impacto económico y social de la industria biotecnológica Cubana,” available at <www.gestiopolis.com/impacto-economico-y-social-de-la-industria-biotecnologica-cubana> (last visited September 13, 2023).+(last+visited+September+13,+2023).>Google Scholar